Figure 1.

Patient samples used for biomarker assessment following a colorectal anastomosis in the treatment of colon cancer. (IL; interleukin, CRP; C-reactive protein, PCT; procalcitonin, WBCC; white blood cell count, I-FABP; intestinal fatty acid binding protein, MMP; matrix metalloproteinases, TIMP; tissue inhibitor of metalloproteinases, VEGF; vascular endothelial growth factor, EGF; epidermal growth factor, PDGF; platelet-derived growth factor, LPS; lipopolysaccharide). Figure created in Biorender.